Stay updated on Upadacitinib vs Placebo in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA Clinical Trial page
- Check7 days agoChange DetectedA banner announces that NIH is transitioning to the term “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) and links to updates and FAQs.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer’s ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now renders as a 403 Forbidden screen with a basic header and a Home link, replacing the previous study record content. The change removes access to study documents (e.g., PDFs, SAP, IPD sharing information) and other materials.SummaryDifference20%

- Check56 days agoChange DetectedA related topics section was expanded to include Rheumatoid arthritis and a MedlinePlus Genetics cross-reference, linking the page to broader topic resources without changing the study details.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, representing a new version of the study page. This indicates a minor page update or maintenance change rather than content changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Placebo in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.